Siegfried Holding AG (SFZN.SW)
- Previous Close
870.00 - Open
872.00 - Bid --
- Ask --
- Day's Range
865.00 - 876.00 - 52 Week Range
655.00 - 950.00 - Volume
4,118 - Avg. Volume
6,721 - Market Cap (intraday)
3.757B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
33.45 - EPS (TTM)
26.19 - Earnings Date Feb 20, 2024
- Forward Dividend & Yield 3.60 (0.41%)
- Ex-Dividend Date May 3, 2024
- 1y Target Est
1,005.36
Siegfried Holding AG, together with its subsidiaries, provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. It offers pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale-up and clinical trial material production services. The company develops and produces APIs and intermediates, as well as finished dosage forms, including solid oral dosage forms, sterile and aseptic filling injectables, ophthalmics, and inhalative products. In addition, it provides APIs and controlled substances focusing on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition; exclusive synthesis services comprising process and chemical development, analytical development, pilot manufacturing and scale-up, and commercial manufacturing; and viral vector manufacturing solutions. Further, the company licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for products. Siegfried Holding AG was founded in 1873 and is headquartered in Zofingen, Switzerland.
www.siegfried.ch3,819
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: SFZN.SW
Performance Overview: SFZN.SW
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SFZN.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SFZN.SW
Valuation Measures
Market Cap
3.76B
Enterprise Value
3.70B
Trailing P/E
33.41
Forward P/E
26.60
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.96
Price/Book (mrq)
4.48
Enterprise Value/Revenue
2.91
Enterprise Value/EBITDA
15.35
Financial Highlights
Profitability and Income Statement
Profit Margin
8.86%
Return on Assets (ttm)
6.00%
Return on Equity (ttm)
13.83%
Revenue (ttm)
1.27B
Net Income Avi to Common (ttm)
112.69M
Diluted EPS (ttm)
26.19
Balance Sheet and Cash Flow
Total Cash (mrq)
56.63M
Total Debt/Equity (mrq)
53.09%
Levered Free Cash Flow (ttm)
64.53M
Research Analysis: SFZN.SW
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: SFZN.SW
SFZN.SW does not have Company Insights